Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Reporting trends, practices, and resource utilization in neuroendocrine tumors of the prostate gland: a survey among thirty-nine genitourinary pathologists

Mohanty, Sambit K., Lobo, Anandi, Williamson, Sean R., Shah, Rajal B., Trpkov, Kiril, Varma, Murali, Sirohi, Deepika, Aron, Manju, Kandukari, Shivani R., Balzer, Bonnie L., Luthringer, Daniel L., Ro, Jae, Osunkoya, Adeboye O., Desai, Sangeeta, Menon, Santosh, Nigam, Lovelesh K., Sardana, Rohan, Roy, Paromita, Kaushal, Seema, Midha, Divya, Swain, Minakshi, Ambekar, Asawari, Mitra, Suvradeep, Rao, Vishal, Soni, Shailesh, Jain, Kavita, Diwaker, Preeti, Pattnaik, Niharika, Sharma, Shivani, Chakrabarti, Indranil, Sable, Mukund, Jain, Ekta, Jain, Deepika, Samra, Spinder, Vankalakunti, Mahesha, Mohanty, Subhashis, Parwani, Anil V., Sancheti, Sankalp, Kumari, Niraj, Jha, Shilpy, Dixit, Mallika, Malik, Vipra, Arora, Samriti, Munjal, Gauri, Gopalan, Anuradha, Magi-Galluzzi, Cristina and Dhillon, Jasreman 2023. Reporting trends, practices, and resource utilization in neuroendocrine tumors of the prostate gland: a survey among thirty-nine genitourinary pathologists. International Journal of Surgical Pathology 31 (6) , pp. 993-1005. 10.1177/10668969221116629

[thumbnail of Reporting Trends.pdf] PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution.

Download (1MB)


Background: Neuroendocrine differentiation in the prostate gland ranges from clinically insignificant neuroendocrine differentiation detected with markers in an otherwise conventional prostatic adenocarcinoma to a lethal high-grade small/large cell neuroendocrine carcinoma. The concept of neuroendocrine differentiation in prostatic adenocarcinoma has gained considerable importance due to its prognostic and therapeutic ramifications and pathologists play a pivotal role in its recognition. However, its awareness, reporting, and resource utilization practice patterns among pathologists are largely unknown. Methods: Representative examples of different spectrums of neuroendocrine differentiation along with a detailed questionnaire were shared among 39 urologic pathologists using the survey monkey software. Participants were specifically questioned about the use and awareness of the 2016 WHO classification of neuroendocrine tumors of the prostate, understanding of the clinical significance of each entity, and use of different immunohistochemical (IHC) markers. De-identified respondent data were analyzed. Results: A vast majority (90%) of the participants utilize IHC markers to confirm the diagnosis of small cell neuroendocrine carcinoma. A majority (87%) of the respondents were in agreement regarding the utilization of type of IHC markers for small cell neuroendocrine carcinoma for which 85% of the pathologists agreed that determination of the site of origin of a high-grade neuroendocrine carcinoma is not critical, as these are treated similarly. In the setting of mixed carcinomas, 62% of respondents indicated that they provide quantification and grading of the acinar component. There were varied responses regarding the prognostic implication of focal neuroendocrine cells in an otherwise conventional acinar adenocarcinoma and for Paneth cell-like differentiation. The classification of large cell neuroendocrine carcinoma was highly varied, with only 38% agreement in the illustrated case. Finally, despite the recommendation not to perform neuroendocrine markers in the absence of morphologic evidence of neuroendocrine differentiation, 62% would routinely utilize IHC in the work-up of a Gleason score 5 + 5 = 10 acinar adenocarcinoma and its differentiation from high-grade neuroendocrine carcinoma. Conclusion: There is a disparity in the practice utilization patterns among the urologic pathologists with regard to diagnosing high-grade neuroendocrine carcinoma and in understanding the clinical significance of focal neuroendocrine cells in an otherwise conventional acinar adenocarcinoma and Paneth cell-like neuroendocrine differentiation. There seems to have a trend towards overutilization of IHC to determine neuroendocrine differentiation in the absence of neuroendocrine features on morphology. The survey results suggest a need for further refinement and development of standardized guidelines for the classification and reporting of neuroendocrine differentiation in the prostate gland.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: SAGE Publications
ISSN: 1066-8969
Date of First Compliant Deposit: 4 January 2023
Date of Acceptance: 9 August 2022
Last Modified: 07 Nov 2023 19:43

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics